levels in the metabolic derangement of diabetes. N Engl J Med 1984;310: 810-5. 19 Hyer SL, Sharp PS, Brooks RA, Burrin JM5 Kohner EM. Serum IGF-1 concentration in diabetic retinopathy. Diabetic Med 1988;5:356-60. 20 Sharp PS, Fall?n TJ, Brazier OJ, Sandier L, Joplin GF, Kohner EM. Long term follow up of patients who underwent yttrium-90 pituitary implantation for treatment of proliferative retinopathy. Diabetologia 1987;33:199-207. 21 Diabetic Retinopathy Study Research Group. Preliminary report on effects of photocoagulation therapy. Am J Ophthalmol 1976;81:383-97. 22 Sullivan PM, Caldwell G, Alexandra N, Kohner EM. Long term outcome after photocoagulation for preproliferative diabetic retinopathy. Diabetic Med 1990;7:788-94. 23 Davies EG, Petty RG, Kohner EM. Long term effectiveness of photocoagula tion for diabetic retinopathy. Eye 1989;3:764-7. 24 British Multicentre Study Group. Photocoagulation for diabetic maculopathy: a randomised controlled clinical trial using the xenon arc. Diabetes 1983;32:1010-6. 25 Early Treatment of Diabetic Retinopathy Study. Photocoagulation for diabetic macular disease: report I. Arch Ophthalmol Vis Sei 1985;103:1798-806. 26 Early Treatment of Diabetic Retinopathy Study. Photocoagulation for diabetic macular oedema: report IV. Int Ophthalmol Clin 1987:27:265-72. 27 Job D, Eschwege E, Guyot-Argenton C, Anbrey JA, Tchobrutsky G. Effect of multiple daily insulin injections on the course of diabetic retinopathy. Diabetes 1976;25:463-9. 28 Kroc Collaborative Study Group. Blood glucose control and the evolution of diabetic retinopathy and albuminuria. NEnglJMed 1984;311:365-72. 29 Brinchmann-Hansen O, Dahl-Jorgensen K, Hanssen KF, Sanduik L. The response of diabetic retinopathy to 41 months of multiple insulin injections, insulin pumps and conventional insulin* therapy. Arch Ophthalmol 1988;106: 1242-6. , , i '; 30 Reichard P, Bengt-Yngue N, Rosenqiiiet ?. Th? effect of long tenn intensified insulin treatment on the develo?nient of microvascular c?iaplica tions of diabetes mellitus. NEnglJMed 1993;32#30&9v 31 United Kingdom Prospective Diabetes Study. Study design and progress and performance. Diabetologia 1991 ;34:877-90. * ,.'.???*'? ^ v 32 WHO/IDF Europe. Diabetes and research in Europe: the St Vincent declaration. Diabetic Med 1990;7:360. 33 Kohner EM, Porta M. Screening for diabetic retinopathy in Europe: a field guide book. Milan: Boehringer Mannheim, 1992.
[1]
M. Baum,et al.
Ethics of clinical research: lessons for the future.
,
1989,
BMJ.
[2]
Earlybreastcancertrialistscol,et al.
Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy 133 randomised trials involving 31 000 recurrences and 24 000 deaths among 75 000 women
,
1992,
The Lancet.
[3]
A. Coates,et al.
Special article: Redressing the balance - The ethics of not entering an eligible patient on a randomised clinical trial Point of view
,
1992
.
[4]
Guidelines on the Practice of Ethics Committees in Medical Research Involving Human Subjects
,
1992,
Journal of the Royal College of Physicians of London.
[5]
H. Thornton.
Breast cancer trials: a patient's viewpoint
,
1992,
The Lancet.
[6]
S Hellman,et al.
Of mice but not men. Problems of the randomized clinical trial.
,
1991,
The New England journal of medicine.
[7]
Gruppo Italiano per lo Studio della Soprawivenza nell'Inf Miocardico.,et al.
EFFECTIVENESS OF INTRAVENOUS THROMBOLYTIC TREATMENT IN ACUTE MYOCARDIAL INFARCTION
,
1986,
The Lancet.
[8]
A. Coates,et al.
Redressing the balance--the ethics of not entering an eligible patient on a randomised clinical trial.
,
1992,
Annals of oncology : official journal of the European Society for Medical Oncology.